IRF2 is a master regulator of human keratinocyte stem cell fate

Nicolas Mercado(Novartis (Switzerland)), Susan C. Kirkland(Novartis (Switzerland)), Felix Lohmann(Pathways Behavioral Services), Mathias Frederiksen(Novartis (Switzerland)), Sebastian Bergling(Novartis (Switzerland)), Guglielmo Roma(Novartis (Switzerland)), Rémi Terranova, John Reece-Hoyes(University of Massachusetts Chan Medical School), Judith Knehr(Novartis (Switzerland)), Adrian Salathe(Novartis (Switzerland)), Caroline Gubser Keller(Novartis (Switzerland)), John Alford(The University of Melbourne), Hadley E. Sheppard(Baylor College of Medicine), Charles Y. Lin(Kronos Bios (United Kingdom)), Selma Z. Elsarrag(Baylor College of Medicine), Alexandra Aebi(Novartis (Switzerland)), David Estoppey(Novartis (Switzerland)), Florian Nigsch(Novartis (Switzerland)), Tanner C. Beck(Baylor College of Medicine), Tewis Bouwmeester(Institute of Pathology Celle), Gabi Schutzius(Novartis (Switzerland)), Heinz Ruffner(Novartis (Switzerland)), Dominic Hoepfner(Novartis (Switzerland)), Christian Kolter(Novartis (Switzerland)), Carsten Russ(Broad Institute), Sajjeev Jagannathan(University of Cincinnati Medical Center)
Nature Communications
October 14, 2019
Cited by 38


Related Papers